Gilead Sciences Inc issued a recall of two lots of Veklury (remdesivir) injections due to the presence of glass particulates. Remdesivir is indicated for the treatment of severe COVID-19 that requires hospitalization. The administration of an injectable product containing glass particulates may result in local irritation or swelling. If the particulates reach the blood vessels it can travel to various organs and block vessels in the heart, lungs, or brain, which can cause stroke and death. The lots impacted at 2141001-1A and 2141002-1A.
